Citations

Showing 10 of 108081 citations.

Post-progression therapy (PPT) effect on survival in AVF2107, a phase III trial of bevacizumab in first-line treatment of metastatic colorectal cancer (mCRC)
Hedrick, Eric, Hurwitz, Herbert I. , Sarkar, Somnath , Griffing, S., Novotny, William , Grothey, Axel

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3517-3517

10.1200/jco.2004.22.90140.3517 Get It

ABX-EGF monotherapy in patients (pts) with metastatic colorectal cancer (mCRC): An updated analysis
Hecht, J. Randolph, Patnaik, Amita , Malik, Imtiaz A. , Venook, A., Croghan, Gary A., Visonneau, S, Jerian, S., Meropol, Neal J. , Venook, Alan P. , Berlin, Jordan D. , Wiens, Brian L.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3511-3511

10.1200/jco.2004.22.90140.3511 Get It

Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 12,915 patients on 15 randomized trials
Wieand, Sam, Benedetti, Jacqueline, Haller, Daniel G. , Shepherd, L. E., Seitz, J. F., Francini, Guido, Gramont, Armand de, Goldberg, Richard M. , Sargent, Daniel J. , Labianca, Roberto

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3502-3502

10.1200/jco.2004.22.90140.3502 Get It

Bcl-2 overexpression attenuates apoptosis induction by sulindac sulfide in SW480 human colon cancer cells
Penington, Robert C., Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3195-3195

10.1200/jco.2004.22.90140.3195 Get It

A phase I trial of the farnesyltransferase (FT) inhibitor, BMS-214662 (B) in combination with paclitaxel (P) and carboplatin (C) in patients with advanced cancer
Dy, Grace K. , Bruzek, Laura M., Croghan, Gary A., Mandrekar, Sumithra J. , Peethambaram, Prema P. , Hanson, L., Erlichman, Charles , Cheng, Shinta

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3066-3066

10.1200/jco.2004.22.90140.3066 Get It

A phase I trial of gemcitabine (Gem), 17-allylaminogeldanamycin (17-AAG) and cisplatin (CDDP) in solid tumor patients
Toft, D O, Steinmetz, Susan , Furth, Alfred, Mandrekar, Sumithra J. , Stensgard, Bridget, McCollum, Andrea K., Hanson, L., Adjei, Alex A. , Erlichman, Charles , Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3058-3058

10.1200/jco.2004.22.90140.3058 Get It

Phase I trial of OSI-774 and CPT-11 in patients with advanced solid tumors
Rao, Ravi D., Furth, Alfred, Mandrekar, Sumithra J. , Adjei, Alex A. , Ames, Matthew M. , Erlichman, Charles , Pitot, Henry C., Reid, Joel M. , Goetz, Matthew P. , Safgren, Stephanie L.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3053-3053

10.1200/jco.2004.22.90140.3053 Get It

A phase I trial of 17-allylamino-geldanamycin (17AAG) in patients with advanced cancer
Erlichman, Charles , Toft, D O, Reid, J., Ames, M. M., Mandrekar, Sumithra J. , Ajei, A., McCollum, Andrea K., Ivy, Percy, Goetz, Matthew P.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3030-3030

10.1200/jco.2004.22.90140.3030 Get It

Sequential plasmid vaccinations targeting normal melanocytes protects against challenge with melanoma in a syngenic murine model
Daniels, Gregory A. , Vile, Richard G.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 2570-2570

10.1200/jco.2004.22.90140.2570 Get It

Antigen presenting cell based immunotherapy targeting HER2/Neu positive solid tumors: Results of a phase 1 study of APC8024
Peethambaram, Prema P. , Rinn, Kristine , Jones, Lori , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 2528-2528

10.1200/jco.2004.22.90140.2528 Get It